Manager of Commercial Operations & Analytics, Ceribell
$140-180k
+ Annual Bonus Opportunity + Ceribell Equity
Office located in Sunnyvale, CA
Portable seizure diagnostics technology
Job no longer available
Portable seizure diagnostics technology
201-500 employees
Job no longer available
$140-180k
+ Annual Bonus Opportunity + Ceribell Equity
Office located in Sunnyvale, CA
201-500 employees
Company mission
To make EEG widely accessible, more efficient, and more cost-effective to improve the diagnosis and treatment of patients at risk for seizure.
Jump to section
Company mission
To make EEG widely accessible, more efficient, and more cost-effective to improve the diagnosis and treatment of patients at risk for seizure.
Our take
Ceribell has created a cloud-based, AI-enabled electroencephalography (EEG) headset which helps diagnose seizures without the presence of an EEG technologist or specialist interpreter, allowing for faster diagnosis and better treatment.
Though founded back in 2014, Ceribell experienced a huge breakthrough in 2022 when its system was granted FDA clearance to help diagnose suspected seizures, which has led to a boost in venture capital investment.
The company has also gone on to receive the FDA’s Breakthrough Device Designation for its ability to diagnose delirium, or acute brain failure and was placed on the World's Most Innovative COmpanies List 2023 by the Fast Company. Ceribell has no plans on stopping there though, and intends to grow its team rapidly in a bid to expand its tech capabilities for a range of other neurological conditions.
Steph
Company Specialist at Welcome to the Jungle
Benefits
- 100% Employer Paid Health, Dental and Vision for the Employee
- 50%- 70% Employer Paid Heath, Dental and Vision for dependents (according to plan selection)
- Ceribell equity
- A flexible vacation policy and 11 paid holidays
- Monthly cell phone reimbursement
- Flex spending account, life insurance, and disability insurance
- Excellent parental leave policy
- Joining a mission minded organization!
Company values
- Transformative – The Ceribell team aspires to be a changing force within healthcare, bringing disruptive technologies to market and improving diagnostics and treatment. To achieve our goals, we relentlessly push boundaries and are always action oriented
- Patient Focused – We care about each and every patient our products touch because we know every life is precious. We are committed to making a positive impact on healthcare one family at a time
- Passionate – We are passionate about the roles we play individually and collectively. Ceribell fosters an environment that advances both the personal and professional growth of our team members, while also embracing the differences within our community
Funding (last 2 of 4 rounds)
Sep 2022
$50m
SERIES C
Apr 2021
$53m
SERIES C
Total funding: $151m
This company has top investors
Leadership
Xingjuan (Jane) Chao
(CEO & Co-Founder)Ph.D. in biophysics from Cornell University. Former Management Consultant with McKinsey & Company, later joining Novartis as Senior Strategy Manager. Principal Manager of Portfolio Management Strategy at Genentech before co-founding Ceribell.
Josef Parvizi
(Co-Founder)Professor of Neurology at Stanford University School of Medicine since 2007. Previously worked in Internal Medicine Intern at Mayo Clinic.
Chris Chafe
(Co-founder)Composer, Cellist, and Researcher. Director of Stanford University's Center for Computer Research in Music and Acoustics (CCRMA), and Duca Family Professor of Humanities and Sciences.
Articles
Jobs (6)
Software Engineering
People, HR, Recruitment
Other Engineering
Sales & Account Management